ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,711.57
      0.05%
      US Tech 100
      19,306.80
      0.29%
      Dow Jones
      42,206.64
      0.12%
      Brent Oil
      74.405
      -0.02%
      Bitcoin
      60,125.81
      -1.16%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Atossa Therapeutics Inc (ATOS)

      7. Atossa Therapeutics Inc (ATOS) Financials

      Atossa Therapeutics Inc

      Atossa Therapeutics Inc (ATOS)

      NASDAQ
      1.45
      -0.01
      ( -0.68% )
      Updated: 15:21:05
      Delayed by 15 minutes

      Atossa Therapeutics Inc Financial Summary

      The current ATOS market cap is 182.35M. The company's latest EPS is USD -0.2393 and P/E is -6.10.

      Income Statement

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 00000
      Operating Income -7.79M-7.47M-9.02M-6.98M-7.11M
      Net Income -9.83M-6.23M-7.75M-5.88M-6.05M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 00000
      Operating Income -17.27M-15.55M-20.61M-27.69M-31.38M
      Net Income -17.24M-22.33M-20.61M-26.96M-30.09M

      Balance Sheet

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 108.36M101.7M96.25M91.09M85.86M
      Total Liabilities 3.48M3.44M5.24M5.33M5.7M
      Total Equity 104.88M98.25M91.02M85.76M80.16M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 14.49M42.84M141.26M123.53M96.25M
      Total Liabilities 1.33M15.67M3.13M5.57M5.24M
      Total Equity 13.16M27.17M138.14M117.96M91.02M

      Cash Flow

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -11.49M-15.37M-20.94M-4.7M-9.23M
      Investing -13k-14k-14k-6k-9k
      Financing N/A -1.48M-1.48M204k304k
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -9.13M-11.57M-16.47M-20.76M-20.94M
      Investing -8k-9k-9k-4.73M-14k
      Financing 11.34M38.55M113.3M N/A -1.48M

      Stats and Ratios

      Market Cap 182.35M
      Price to Earnings Ratio -6.10
      Price to Sales Ratio 0
      Price to Cash Ratio 2.08
      Price to Book Ratio 2.02
      Dividend Yield -

      Share Statistics

      Shares Outstanding 125.76M
      Average Volume (1 week) 567.86k
      Average Volume (1 Month) 564.68k
      52 Week Change 96.88%
      52 Week High 2.31
      52 Week Low 0.62
      Spread (Intraday) 0.01 (0.68%)

      Company Info

      Company Name Atossa Therapeutics Inc
      Address 251 little falls drive
      wilmington, delaware 19808
      Website https://www.atossatherapeutics.com
      Industry pharmaceutical preparations (2834)